AGEN ▲ +0.1% - Agenus Inc.
$AGEN Agenus Announces Nature Medicine Publication of Multicenter UNICORN Phase 2 Trial Demonstrating Deep Responses with Neoadjuvant BOT+BAL in Resectable Colon Cancer
02-NOV-2026 06:46 AM ET
Share this post
More filings for $AGEN
AGEN - Agenus Inc. - SEC Filing Update (16-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 17, 2026AGEN ▲ +0.3% - Agenus Inc.Oct 8, 2026AGEN ▼ -1.0% - Agenus Inc.Oct 3, 2026AGEN ▲ +1.1% - Agenus Inc.Oct 2, 2026$AGEN SEC Filing Update (27-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 27, 2026$AGEN SEC Filing Update (20-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 20, 2026
View full $AGEN filing history →💬 Comments
Loading comments…
Leave a comment
